1. Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review

   • Kiran Kumar Rathinam
   • Justin Jacob Abraham
   • Priyadharshini A

   Review 17 January 2022 Pages: 531 - 545

   

2. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants

   • Akshaya Srikanth Bhagavathula
   • Benjamin Woolf
   • Wubshet Tesfaye

   Review 18 January 2022 Pages: 547 - 555

   

3. Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study

   • Vladimír Nosáľ
   • Andrea Petrovičová
   • Marián Mokáň

   Pharmacodynamics 22 January 2022 Pages: 557 - 564

4. A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients

   • Dong Guo
   • Zhirong Tan
   • Hong Yang

   Pharmacogenetics 11 January 2022 Pages: 565 - 578

   

5. Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients

   • Sally H. Preissner
   • Paolo Marchetti
   • Robert Preissner

   Pharmacogenetics Open access 27 December 2021 Pages: 579 - 587

   

6. Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide

   • Jiangchuan Long
   • Yongjian Liu
   • Dongfang Liu

   Pharmacogenetics 15 January 2022 Pages: 589 - 596

   

7. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib

   • Jeffry Adiwidjaja
   • Alan V. Boddy
   • Andrew J. McLachlan

   Pharmacokinetics and Disposition 20 January 2022 Pages: 597 - 611

   

8. Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant

   • Hideyuki Hibino
   • Naomi Sakiyama
   • Hisakazu Ohtani

   Pharmacokinetics and Disposition 17 January 2022 Pages: 613 - 621

   

9. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis

   • Abdulrhman Al Rowily
   • Zahraa Jalal
   • Vibhu Paudyal

   Pharmacoepidemiology and Prescription Open access 22 December 2021 Pages: 623 - 645

   

10. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease

    • Mengshi Yi
    • Xi Feng
    • Zheyu Chen

    Pharmacoepidemiology and Prescription 15 January 2022 Pages: 647 - 656

    

11. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018

    • Ina-Maria Rückert-Eheberg
    • Michael Nolde
    • Sebastian-Edgar Baumeister

    Pharmacoepidemiology and Prescription Open access 08 December 2021 Pages: 657 - 667

    

12. Drug utilisation in neonatal units in England and Wales: a national cohort study

    • Asma Al-Turkait
    • Lisa Szatkowski
    • Shalini Ojha

    Pharmacoepidemiology and Prescription Open access 13 January 2022 Pages: 669 - 677

    

13. Evaluation of two European risk models for predicting medication harm in an Australian patient cohort

    • Nazanin Falconer
    • Michael Barras
    • Neil Cottrell

    Pharmacoepidemiology and Prescription 18 January 2022 Pages: 679 - 686

    

14. Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity

    • Thierry Trenque
    • Elise Lepoix
    • Brahim Azzouz

    Pharmacoepidemiology and Prescription 06 January 2022 Pages: 687 - 690

15. European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology

    • Andrej Belančić
    • Carla Sans-Pola
    • the EACPT Young Clinical Pharmacologists Working Group

    Special Article 17 January 2022 Pages: 691 - 694

    

16. Updated network meta-analysis assessing the relative efficacy of 13 GLP-1 RA and SGLT2 inhibitor interventions on cardiorenal and mortality outcomes in type 2 diabetes

    • Mei Qiu
    • Wei Wei
    • Shu-Yan Liu

    Letter to the Editor 03 December 2021 Pages: 695 - 697

    

17. Elevation of alkaline phosphatase and long-term drug therapy for cystic fibrosis

    • Quentin Delmez
    • Vincent Haufroid
    • Philippe Hantson

    Letter to the Editor 15 January 2022 Pages: 699 - 701

    

18. Severe CNS depression with duloxetine, ciprofloxacin and CYP2D6 deficiency—role and recognition of drug-drug-gene interactions

    • Matthias Hoffmann
    • Stefan Russmann
    • David F. Niedrig

    Letter to the Editor 17 January 2022 Pages: 703 - 705